ITEMS IN AFP WITH KEYWORD:

Arthritis

Sep 15, 2007 Issue
Gout: An Update [Article]

Arthritis caused by gout (i.e., gouty arthritis) accounts for millions of outpatient visits annually, and the prevalence is increasing. Gout is caused by monosodium urate crystal deposition in tissues leading to arthritis, soft tissue masses (i.e., tophi), nephrolithiasis, and urate nephropathy. The...


Sep 1, 2007 Issue
The Role of Allergens in Asthma [Article]

The National Asthma Education and Prevention Program Expert Panel guidelines for the management of asthma recommend that patients who require daily asthma medications have allergy testing for perennial indoor allergens and that, when triggers are found, exposure to allergens and pollutants be contro...


Feb 1, 2006 Issue
Adalimumab for Rheumatoid Arthritis? [Cochrane for Clinicians]

Combined with methotrexate, subcutaneous adalimumab at a dosage of 40 mg every two weeks slows the progression of rheumatoid arthritis at one year. The combination is more effective than adalimumab monotherapy. Limited evidence suggests that adalimumab is also safe and effective when combined with o...


Sep 15, 2005 Issue
Diagnosis and Management of Rheumatoid Arthritis [Article]

Rheumatoid arthritis is a chronic inflammatory disease characterized by uncontrolled proliferation of synovial tissue and a wide array of multisystem comorbidities. Prevalence is estimated to be 0.8 percent worldwide, with women twice as likely to develop the disease as men. Untreated, 20 to 30 perc...


Nov 1, 2003 Issue
Rheumatoid Arthritis [Clinical Evidence Handbook]

What are the effects of treatments?


Sep 15, 2003 Issue
Diagnostic Approach to Polyarticular Joint Pain [Article]

Identifying the cause of polyarticular joint pain can be difficult because of the extensive differential diagnosis. A thorough history and a complete physical examination are essential. Six clinical factors are helpful in narrowing the possible causes: disease chronology, inflammation, distribution,...


Sep 1, 2003 Issue
Is Leflunomide as Safe and Effective in the Treatment of Rheumatoid Arthritis as Other DMARDs? [Cochrane for Clinicians]

Compared with placebo, leflunomide improves clinical outcomes and delays radiologic progression of rheumatoid arthritis. After two years of treatment, leflunomide is as safe as sulfasalazine and more effective. Leflunomide's efficacy and adverse events are similar to those of methotrexate. Leflunomi...


Jul 1, 2003 Issue
Diagnosing Acute Monoarthritis in Adults: A Practical Approach for the Family Physician [Article]

Acute monoarthritis can be the initial manifestation of many joint disorders. The first step in diagnosis is to verify that the source of pain is the joint, not the surrounding soft tissues. The most common causes of monoarthritis are crystals (i.e., gout and pseudogout), trauma, and infection. A ca...


Mar 15, 2002 Issue
Clinical Utility of Common Serum Rheumatologic Tests [Article]

Serum rheumatologic tests are generally most useful for confirming a clinically suspected diagnosis. Testing for rheumatoid factor is appropriate when rheumatoid arthritis, Sjögren's syndrome or cryoglobulinemia is suspected. Antinuclear antibody testing is highly sensitive for systemic lupus eryth...


Mar 1, 2002 Issue
Osteoarthritis: Diagnosis and Therapeutic Considerations [Article]

Osteoarthritis is a common rheumatologic disorder. It is estimated that 40 million Americans and 70 to 90 percent of persons older than 75 years are affected by osteoarthritis. Although symptoms of osteoarthritis occur earlier in women, the prevalence among men and women is equal. In addition to age...


Pages: Previous 1 2 3 4 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now